{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:58:23Z","timestamp":1792511903735,"version":"4.5.0"},"reference-count":99,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030692","name":"Intramural Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sudden cardiac death is a common but poorly understood cause of mortality in Fabry disease (FD). We investigated the arrhythmogenic mechanisms using a new approach methodology model of FD. This model employed optical mapping of membrane potentials and calcium transient (CaT) with adenovirus-mediated replacement of GLA (advGLA) in stem cell-derived ventricular cardiomyocytes (VCMs) of WT and FD origin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\u03b1-Galactosidase A (GLA) null and wild-type (WT; iPS-DF19-9-11T) stem cells were differentiated into VCMs using a GiWi protocol, selected using MACS, and matured on MatrixPlus-coated 96- or 6-well plates for 7 days. GLA-null, wild-type, and adenoviral-transfected GLA ventricular cardiomyocytes were then subjected to optical mapping to measure membrane potentials using Fluovolt and calcium transients using Calbryte 520AM. In addition, cells underwent poly(A)-enriched RNA sequencing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fabry disease-derived matured cardiomyocyte syncytia presented a wide array of arrhythmias, including tachyarrhythmias, early after depolarizations, quiescence, and beat irregularity, compared with wild-type cardiomyocytes. Furthermore, optical mapping of intracellular calcium transients indicated that GLA-null ventricular cardiomyocytes presented an altered frequency of intracellular calcium release, prolonged calcium transient duration at 80% return to baseline, increased calcium transient triangulation, decreased calcium fluorescence upstroke, and higher baseline calcium fluorescence and amplitude relative to wild-type cardiomyocytes. Furthermore, in response to isoproterenol, the relative change in contraction frequency was higher in GLA-null cardiomyocytes compared with wild-type ventricular cardiomyocytes, whereas the change in baseline fluorescence was lower. Transcriptomic analysis indicated that several genes encoding sodium channels subunits (five genes), potassium channel subunits (29 genes), and calcium channels (nine genes) were differentially expressed between GLA-null and wild-type ventricular cardiomyocytes. Adenovirus-mediated rescue of GLA expression (advGLA) did not reduce the frequency of arrhythmias. In addition, treatment of GLA-null cardiomyocytes with advGLA equalized the expression of sodium channel genes (eight genes), potassium channel genes (32 genes), and calcium channel genes (12 genes) relative to wild-type cardiomyocytes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We developed a new approach methodology for Fabry disease-associated arrhythmias using hiPSC-VCMs, which are characterized by a high frequency of arrhythmias associated with widespread dysregulation of ion channel expression. GLA overexpression was unable to restore appropriate ion channel expression and eliminate arrhythmias.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1769383","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:22:34Z","timestamp":1776918154000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A new approach methodology for studying intrinsic ventricular arrhythmias in Fabry disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Andre","family":"Monteiro da Rocha","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Cardiology, University of Michigan","place":["Ann Arbor, MI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology, University of Michigan","place":["Ann Arbor, MI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakaimuk","family":"Saraithong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardiology, University of Michigan","place":["Ann Arbor, MI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erinn","family":"Laimon-Thomson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardiology, University of Michigan","place":["Ann Arbor, MI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalai","family":"Muthukumarasamy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardiology, University of Michigan","place":["Ann Arbor, MI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Herron","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardiology, University of Michigan","place":["Ann Arbor, MI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Shayman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology, University of Michigan","place":["Ann Arbor, MI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1136\/jmg-2022-108523","article-title":"Prevalence of Fabry disease-causing variants in the UK Biobank","volume":"60","author":"Gilchrist","year":"2023","journal-title":"J Med Genet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1136\/jmedgenet-2017-105080","article-title":"Fabry disease: prevalence of affected males and heterozygotes with pathogenic GLA mutations identified by screening renal, cardiac and stroke clinics, 1995\u20132017","volume":"55","author":"Doheny","year":"2018","journal-title":"J Med Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI114027","article-title":"Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene","volume":"83","author":"Bernstein","year":"1989","journal-title":"J Clin Invest"},{"key":"B4","first-page":"1186","article-title":"Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease","volume":"53","author":"Eng","year":"1993","journal-title":"Am J Hum Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1242\/jcs.25.1.17","article-title":"Gene transfer by means of cell fusion I. Statistical mapping of the human X-chromosome by analysis of radiation-induced gene segregation","volume":"25","author":"Goss","year":"1977","journal-title":"J Cell Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/BF00485346","article-title":"X-linked inheritance of a structural gene for alpha-galactosidase in Mus musculus","volume":"14","author":"Lusis","year":"1976","journal-title":"Biochem Genet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1042\/BJ20070479","article-title":"Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin","volume":"406","author":"Ishii","year":"2007","journal-title":"Biochem J"},{"key":"B8","first-page":"113","article-title":"Fabry disease: molecular genetics of the inherited nephropathy","volume":"18","author":"Desnick","year":"1989","journal-title":"Adv Nephrol Necker Hosp"},{"key":"B9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0022-510x(89)90113-5","article-title":"Accumulation of glycosphingolipids in spinal and sympathetic ganglia of a symptomatic heterozygote of Fabry\u2019s disease","volume":"90","author":"Hozumi","year":"1989","journal-title":"J Neurol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2169\/internalmedicine.41.983","article-title":"Fabry disease with few clinical signs and symptoms","volume":"41","author":"Asahi","year":"2002","journal-title":"Intern Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/pgmj.73.865.710","article-title":"Fabry\u2019s disease: a multidisciplinary disorder","volume":"73","author":"Peters","year":"1997","journal-title":"Postgrad Med J"},{"key":"B12","author":"Mehta","year":"1993"},{"key":"B13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/0167-5273(85)90179-2","article-title":"Progressive cardiac involvement by Fabry\u2019s disease despite successful renal allotransplantation","volume":"7","author":"Kramer","year":"1985","journal-title":"Int J Cardiol"},{"key":"B14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2340\/000155555363366","article-title":"On the diagnosis of Fabry\u2019s disease","volume":"55","author":"Wadskov","year":"1975","journal-title":"Acta Derm Venereol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","article-title":"Cardiac involvement in Fabry disease: JACC review topic of the week","volume":"77","author":"Pieroni","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.3390\/ijms22094434","article-title":"Fabry disease and the heart: a comprehensive review","volume":"22","author":"Azevedo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","article-title":"Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry registry","volume":"11","author":"Waldek","year":"2009","journal-title":"Genet Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11897-024-00645-1","article-title":"Fabry disease: cardiac implications and molecular mechanisms","volume":"21","author":"Weissman","year":"2024","journal-title":"Curr Heart Fail Rep"},{"key":"B19","first-page":"516","article-title":"Agalsidase alfa long-term effect on left ventricular hypertrophy in Fabry disease","volume":"84","author":"Ferrari","year":"2024","journal-title":"Medicina (B Aires)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1714\/3934.39176","article-title":"Diagnosis of cardiovascular involvement in Fabry disease","volume":"24","author":"Citro","year":"2023","journal-title":"G Ital Cardiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"C200","DOI":"10.1093\/eurheartjsupp\/suad045","article-title":"Cardiac magnetic resonance in Fabry disease","volume":"25","author":"Lanzillo","year":"2023","journal-title":"Eur Heart J Suppl"},{"key":"B22","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/diagnostics13030354","article-title":"ECG Changes during adult life in Fabry disease: results from a large longitudinal cohort study","volume":"13","author":"El Sayed","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e207363","DOI":"10.14503\/THIJ-20-7363","article-title":"Arrhythmia burden and heart rate response during exercise in Anderson-Fabry disease","volume":"49","author":"Powell","year":"2022","journal-title":"Tex Heart Inst J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/jce.15409","article-title":"Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson-Fabry disease","volume":"33","author":"Tassetti","year":"2022","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/ejhf.1960","article-title":"An expert consensus document on the management of cardiovascular manifestations of Fabry disease","volume":"22","author":"Linhart","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1161\/01.CIR.0000139847.74101.03","article-title":"Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy","volume":"110","author":"Chimenti","year":"2004","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","article-title":"Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey","volume":"28","author":"Linhart","year":"2007","journal-title":"Eur Heart J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"100623","DOI":"10.1016\/j.ymgmr.2020.100623","article-title":"Massive accumulation of globotriaosylceramide in various tissues from a Fabry patient with a high antibody titer against alpha-galactosidase A after 6 years of enzyme replacement therapy","volume":"24","author":"Hongo","year":"2020","journal-title":"Mol Genet Metab Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.carpath.2018.11.002","article-title":"Lysosomal storage disorders affecting the heart: a review","volume":"39","author":"Nair","year":"2019","journal-title":"Cardiovasc Pathol"},{"key":"B30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-981-97-0048-6_4","article-title":"New approach methodologies (NAMs): rethinking preclinical evaluation of pharmaceuticals and medical devices beyond animal models","volume-title":"Animal Models in Research: Principles and Practice","author":"Kasoju","year":"2024"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1093\/hmg\/ddy248","article-title":"Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types","volume":"27","author":"Welford","year":"2018","journal-title":"Hum Mol Genet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/978-1-0716-2910-9_20","article-title":"Inhibitors of glucosylceramide synthase","volume":"2613","author":"Shayman","year":"2023","journal-title":"Methods Mol Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1681\/ASN.2005040383","article-title":"An in vitro model of Fabry disease","volume":"16","author":"Shu","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e64364","DOI":"10.3791\/64364","article-title":"High-throughput cardiotoxicity screening using mature human induced pluripotent stem cell-derived cardiomyocyte monolayers","volume":"193","author":"Monteiro da Rocha","year":"2023","journal-title":"J Vis Exp"},{"key":"B35","doi-asserted-by":"publisher","first-page":"107142","DOI":"10.1016\/j.isci.2023.107142","article-title":"High-throughput longitudinal electrophysiology screening of mature chamber-specific hiPSC-CMs using optical mapping","volume":"26","author":"Allan","year":"2023","journal-title":"iScience"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e99941","DOI":"10.1172\/jci.insight.99941","article-title":"Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes","volume":"3","author":"Cyganek","year":"2018","journal-title":"JCI Insight"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e134368","DOI":"10.1172\/jci.insight.134368","article-title":"In vitro model of ischemic heart failure using human induced pluripotent stem cell-derived cardiomyocytes","volume":"6","author":"Davis","year":"2021","journal-title":"JCI Insight"},{"key":"B38","doi-asserted-by":"publisher","first-page":"100296","DOI":"10.1016\/j.bpsgos.2024.100296","article-title":"Bipolar patient-specific in vitro diagnostic test reveals underlying cardiac arrhythmia phenotype caused by calcium channel genetic risk factor","volume":"4","author":"Dow","year":"2024","journal-title":"Biol Psychiatry Glob Open Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"19071","DOI":"10.1038\/s41598-020-76052-y","article-title":"Human perinatal stem cell derived extracellular matrix enables rapid maturation of hiPSC-CM structural and functional phenotypes","volume":"10","author":"Block","year":"2020","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"13834","DOI":"10.1038\/s41598-017-13590-y","article-title":"hiPSC-CM monolayer maturation state determines drug responsiveness in high throughput pro-arrhythmia screen","volume":"7","author":"da Rocha","year":"2017","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1093\/bioinformatics\/bty350","article-title":"Snakemake\u2014a scalable bioinformatics workflow engine","volume":"34","author":"Koster","year":"2018","journal-title":"Bioinformatics"},{"key":"B42","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"D419","DOI":"10.1093\/nar\/gky1038","article-title":"PANTHER Version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools","volume":"47","author":"Mi","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1101\/gr.6202607","article-title":"A systems biology approach for pathway level analysis","volume":"17","author":"Draghici","year":"2007","journal-title":"Genome Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1172\/JCI62617","article-title":"TBX5 Drives Scn5a expression to regulate cardiac conduction system function","volume":"122","author":"Arnolds","year":"2012","journal-title":"J Clin Invest"},{"key":"B46","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1161\/CIRCULATIONAHA.122.062193","article-title":"Transcriptional dysregulation underlies both monogenic arrhythmia syndrome and common modifiers of cardiac repolarization","volume":"147","author":"Bersell","year":"2023","journal-title":"Circulation"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/cvr\/cvab045","article-title":"Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT syndrome","volume":"118","author":"Nieto-Mar\u00edn","year":"2022","journal-title":"Cardiovasc Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"f153","DOI":"10.1093\/europace\/eux261","article-title":"Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice","volume":"20","author":"Baig","year":"2018","journal-title":"Europace"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s10545-014-9724-5","article-title":"Effective clearance of GL-3 in a human iPSC-derived cardiomyocyte model of Fabry disease","volume":"37","author":"Itier","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.yjmcc.2018.07.246","article-title":"Generation of Fabry cardiomyopathy model for drug screening using induced pluripotent stem cell-derived cardiomyocytes from a female Fabry patient","volume":"121","author":"Kuramoto","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.ajhg.2023.07.013","article-title":"GLA-modified RNA treatment lowers GB3 levels in iPSC-derived cardiomyocytes from Fabry-affected individuals","volume":"110","author":"Ter Huurne","year":"2023","journal-title":"Am J Hum Genet"},{"key":"B52","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.stemcr.2019.07.004","article-title":"A human stem cell model of Fabry disease implicates LIMP-2 accumulation in cardiomyocyte pathology","volume":"13","author":"Birket","year":"2019","journal-title":"Stem Cell Rep"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1161\/01.cir.103.15.2004","article-title":"Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic","volume":"103","author":"Hondeghem","year":"2001","journal-title":"Circulation"},{"key":"B54","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0022-5223(19)43326-6","article-title":"Mechanisms of ventricular fibrillation during hypothermia. Relative changes in myocardial refractory period and conduction velocity","volume":"51","author":"Mouritzen","year":"1966","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B55","first-page":"120","article-title":"Electrophysiological mechanisms involved in ventricular fibrillation","volume":"52","author":"Zipes","year":"1975","journal-title":"Circulation"},{"key":"B56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/eurheartj\/5.suppl_b.19","article-title":"Pathophysiology of re-entrant dysrhythmias","author":"Olsson","year":"1984","journal-title":"Eur Heart J"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/01.cir.81.3.1024","article-title":"Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart","volume":"81","author":"Anderson","year":"1990","journal-title":"Circulation"},{"key":"B58","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s11886-024-02053-2","article-title":"Arrhythmogenesis in Fabry disease","volume":"26","author":"Roy","year":"2024","journal-title":"Curr Cardiol Rep"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1323214","DOI":"10.3389\/fcvm.2023.1323214","article-title":"Clinical utilisation of implantable loop recorders in adults with Fabry disease\u2014a multi-centre snapshot study","volume":"10","author":"Roy","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/europace\/eul121","article-title":"Electrophysiological study in a patient with Fabry disease and a short PQ interval","volume":"8","author":"Jastrzebski","year":"2006","journal-title":"Europace"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e009430","DOI":"10.1161\/CIRCIMAGING.119.009430","article-title":"Myocardial storage, inflammation, and cardiac phenotype in Fabry disease after one year of enzyme replacement therapy","volume":"12","author":"Nordin","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"B62","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/jhg.2016.78","article-title":"Long-term enzyme replacement therapy for Fabry disease: efficacy and unmet needs in cardiac and renal outcomes","volume":"61","author":"Kim","year":"2016","journal-title":"J Hum Genet"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.311872","article-title":"Cardiac Kir2.1 and Na(V)1.5 channels traffic together to the sarcolemma to control excitability","volume":"122","author":"Ponce-Balbuena","year":"2018","journal-title":"Circ Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1054\/jelc.2001.28865","article-title":"Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children","author":"Antzelevitch","year":"2001","journal-title":"J Electrocardiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1007\/s00414-024-03264-6","article-title":"Investigating cardiac genetic background in sudden infant death syndrome (SIDS)","volume":"138","author":"Cazzato","year":"2024","journal-title":"Int J Legal Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/j.hrthm.2024.04.047","article-title":"SCN5A gene variants and arrhythmic risk in Brugada syndrome: an updated systematic review and meta-analysis","volume":"21","author":"Doundoulakis","year":"2024","journal-title":"Heart Rhythm"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e012374","DOI":"10.1161\/CIRCEP.123.012374","article-title":"Genetic testing in Brugada syndrome: a 30-year experience","volume":"17","author":"Pannone","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e77843","DOI":"10.1371\/journal.pone.0077843","article-title":"Altered cardiac electrophysiology and SUDEP in a model of Dravet syndrome","volume":"8","author":"Auerbach","year":"2013","journal-title":"PLoS One"},{"key":"B69","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/acn3.51017","article-title":"Cardiac arrhythmias in Dravet syndrome: an observational multicenter study","volume":"7","author":"Shmuely","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e003923","DOI":"10.1161\/CIRCEP.116.003923","article-title":"Scn2b deletion in mice results in ventricular and atrial arrhythmias","volume":"9","author":"Bao","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3892\/ijmm.2013.1355","article-title":"Mutations of the SCN4B-encoded sodium channel beta4 subunit in familial atrial fibrillation","volume":"32","author":"Li","year":"2013","journal-title":"Int J Mol Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e0132888","DOI":"10.1371\/journal.pone.0132888","article-title":"Comprehensive genetic characterization of a Spanish Brugada syndrome cohort","volume":"10","author":"Selga","year":"2015","journal-title":"PLoS One"},{"key":"B73","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/164_2017_48","article-title":"Voltage-gated sodium channel beta subunits and their related diseases","volume":"246","author":"Bouza","year":"2018","journal-title":"Handb Exp Pharmacol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"984299","DOI":"10.3389\/fphar.2022.984299","article-title":"Diagnostic yield and variant reassessment in the genes encoding Nav1.5 channel in Russian patients with Brugada syndrome","volume":"13","author":"Zaklyazminskaya","year":"2022","journal-title":"Front Pharmacol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.neuron.2021.03.012","article-title":"A central mechanism of analgesia in mice and humans lacking the sodium channel Na(V)1.7","volume":"109","author":"MacDonald","year":"2021","journal-title":"Neuron"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e882","DOI":"10.1097\/j.pain.0000000000002535","article-title":"Congenital insensitivity to pain: a novel mutation affecting a U12-type intron causes multiple aberrant splicing of SCN9A","volume":"163","author":"Marchi","year":"2022","journal-title":"Pain"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.2147\/JPR.S375299","article-title":"Familial episodic pain syndromes","volume":"15","author":"Shen","year":"2022","journal-title":"J Pain Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13023-015-0347-1","article-title":"Primary erythromelalgia: a review","volume":"10","author":"Tang","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"B79","doi-asserted-by":"publisher","first-page":"913990","DOI":"10.3389\/fnmol.2022.913990","article-title":"The human SCN9A (R185H) point mutation induces pain hypersensitivity and spontaneous pain in mice","volume":"15","author":"Xue","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"B80","doi-asserted-by":"publisher","first-page":"8842398","DOI":"10.1155\/2020\/8842398","article-title":"Susceptibility to ventricular arrhythmias resulting from mutations in FKBP1B, PXDNL, and SCN9A evaluated in hiPSC cardiomyocytes","volume":"2020","author":"Barajas-Martinez","year":"2020","journal-title":"Stem Cells Int"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"B82","doi-asserted-by":"publisher","first-page":"eaay5947","DOI":"10.1126\/science.aay5947","article-title":"An atlas of the protein-coding genes in the human, pig, and mouse brain","volume":"367","author":"Sj\u00f6stedt","year":"2020","journal-title":"Science"},{"key":"B83","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.hrthm.2023.02.004","article-title":"Standing genetic variation affects phenotypic heterogeneity in an SCN5A-mutation founder population with excess sudden cardiac death","volume":"20","author":"Isaacs","year":"2023","journal-title":"Heart Rhythm"},{"key":"B84","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fncel.2016.00081","article-title":"Potassium channels and human epileptic phenotypes: an updated overview","volume":"10","author":"Villa","year":"2016","journal-title":"Front Cell Neurosci"},{"key":"B85","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1073\/pnas.1218154110","article-title":"KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia","volume":"110","author":"Deo","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B86","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.yjmcc.2004.05.011","article-title":"Loss-of-function mutations of the K(+) channel gene KCNJ2 constitute a rare cause of long QT syndrome","volume":"37","author":"Fodstad","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.hrthm.2014.02.015","article-title":"KCNJ2 mutation causes an adrenergic-dependent rectification abnormality with calcium sensitivity and ventricular arrhythmia","volume":"11","author":"Kalscheur","year":"2014","journal-title":"Heart Rhythm"},{"key":"B88","doi-asserted-by":"publisher","first-page":"6369","DOI":"10.1007\/s00210-024-03116-5","article-title":"The network of cardiac K(IR)2.1: its function, cellular regulation, electrical signaling, diseases and new drug avenues","volume":"397","author":"Li","year":"2024","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/s0092-8674(01)00342-7","article-title":"Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen\u2019s syndrome","volume":"105","author":"Plaster","year":"2001","journal-title":"Cell"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.hrthm.2021.04.008","article-title":"Cardiac potassium inward rectifier Kir2: review of structure, regulation, pharmacology, and arrhythmogenesis","volume":"18","author":"Reilly","year":"2021","journal-title":"Heart Rhythm"},{"key":"B91","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1146\/annurev.cellbio.16.1.521","article-title":"Structure and regulation of voltage-gated Ca2+ channels","volume":"16","author":"Catterall","year":"2000","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/336134a0","article-title":"Restoration of excitation-contraction coupling and slow calcium current in dysgenic muscle by dihydropyridine receptor complementary DNA","volume":"336","author":"Tanabe","year":"1988","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bpj.2008.09.027","article-title":"A CaV1.1 Ca2+ channel splice variant with high conductance and voltage-sensitivity alters EC coupling in developing skeletal muscle","volume":"96","author":"Tuluc","year":"2009","journal-title":"Biophys J"},{"key":"B94","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0006-3495(97)78055-X","article-title":"Heterogeneity of Ca2+ gating of skeletal muscle and cardiac ryanodine receptors","volume":"73","author":"Copello","year":"1997","journal-title":"Biophys J"},{"key":"B95","doi-asserted-by":"publisher","first-page":"24234","DOI":"10.1074\/jbc.272.39.24234","article-title":"Functional characterization of the recombinant type 3 Ca2+ release channel (ryanodine receptor) expressed in HEK293 cells","volume":"272","author":"Chen","year":"1997","journal-title":"J Biol Chem"},{"key":"B96","doi-asserted-by":"publisher","first-page":"C1485","DOI":"10.1152\/ajpcell.1994.266.6.C1485","article-title":"Structure and function of ryanodine receptors","volume":"266","author":"Coronado","year":"1994","journal-title":"Am J Physiol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"31624","DOI":"10.1074\/jbc.R112.349068","article-title":"Ryanodine receptors: structure and function","volume":"287","author":"Van Petegem","year":"2012","journal-title":"J Biol Chem"},{"key":"B98","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1113\/jphysiol.1995.sp021055","article-title":"Ca2+ activation and Ca2+ inactivation of canine reconstituted cardiac sarcoplasmic reticulum Ca(2+)-release channels","volume":"489","author":"Schiefer","year":"1995","journal-title":"J Physiol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1152\/physrev.00013.2002","article-title":"Ryanodine receptor calcium release channels","volume":"82","author":"Fill","year":"2002","journal-title":"Physiol Rev"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1769383\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:22:36Z","timestamp":1776918156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1769383\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":99,"alternative-id":["10.3389\/fcvm.2026.1769383"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1769383","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"article-number":"1769383"}}